The Seagen Acquisition and Pfizer's "All In On Cancer" Bet

The 43 billion dollar Seagen acquisition, completed in December 2023, is the biggest deal in Pfizer's history and the centerpiece of its growth strategy through 2030. Any candidate interviewing for an oncology, R&D, commercial, or strategy role needs to understand this deal, the antibody-drug conjugate technology behind it, and where the integration stands today.